Welcome to LookChem.com Sign In|Join Free
  • or
METHYL 8-NITRO-4-OXO-1,4-DIHYDROQUINOLINE-2-CARBOXYLATE is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

16134-01-3

Post Buying Request

16134-01-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

16134-01-3 Usage

Synthesis Reference(s)

Journal of Medicinal Chemistry, 28, p. 298, 1985 DOI: 10.1021/jm00381a007

Check Digit Verification of cas no

The CAS Registry Mumber 16134-01-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,1,3 and 4 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 16134-01:
(7*1)+(6*6)+(5*1)+(4*3)+(3*4)+(2*0)+(1*1)=73
73 % 10 = 3
So 16134-01-3 is a valid CAS Registry Number.

16134-01-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl 8-nitro-4-oxo-1H-quinoline-2-carboxylate

1.2 Other means of identification

Product number -
Other names 2-methoxycarbonyl-8-nitro-1,4-dihydro-4-oxoquinoline

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:16134-01-3 SDS

16134-01-3Relevant academic research and scientific papers

Folding of a linear array of α-amino acids within a helical aromatic oligoamide frame

Kudo, Mayumi,Maurizot, Victor,Kauffmann, Brice,Tanatani, Aya,Huc, Ivan

, p. 9628 - 9631 (2013)

Control of the spatial organization of proteinogenic side chains is critical for the development of protein mimics with selective recognition properties toward target protein surfaces. We present a novel methodology for producing a linear array of protein

Assembly and optical properties of 1D helical bundles induced by triphenylamine, side chains and solvents in crystals

Li, Baolin,Pang, Zhi,Qi, Ting

supporting information, p. 5555 - 5562 (2021/07/02)

Two novel helical aromatic foldamer derivativesTPA-Q6(n-He)andTPA-Q6(i-Bu)were synthesized and characterized by introducingn-hexyloxy and isobutoxy side chains, respectively, and modifying quinoline amide foldamers with the triphenyl

Foldamer-Based Potassium Channels with High Ion Selectivity and Transport Activity

Qi, Shuaiwei,Zhang, Chenyang,Yu, Hao,Zhang, Jing,Yan, Tengfei,Lin, Ze,Yang, Bing,Dong, Zeyuan

supporting information, p. 3284 - 3288 (2021/04/07)

Small molecules that independently perform natural channel-like functions show greatly potential in the treatment of human diseases. Taking advantage of aromatic helical scaffolds, we develop a kind of foldamer-based ion channels with lumen size varying f

Multifunctional Analogs of Kynurenic Acid for the Treatment of Alzheimer's Disease: Synthesis, Pharmacology, and Molecular Modeling Studies

Deora, Girdhar Singh,Kantham, Srinivas,Chan, Stephen,Dighe, Satish N.,Veliyath, Suresh K.,McColl, Gawain,Parat, Marie-Odile,McGeary, Ross P.,Ross, Benjamin P.

, p. 2667 - 2675 (2017/12/26)

We report the synthesis and pharmacological investigation of analogs of the endogenous molecule kynurenic acid (KYNA) as multifunctional agents for the treatment of Alzheimer's disease (AD). Synthesized KYNA analogs were tested for their N-methyl-d-aspartate (NMDA) receptor binding, mGluR5 binding and function, acetylcholinesterase (AChE) inhibition, 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging, interference with the amyloid β peptide (Aβ) fibrillation process, and protection against Aβ-induced toxicity in transgenic Caenorhabditis elegans strain GMC101 expressing full-length Aβ42. Molecular modeling studies were also performed to predict the binding modes of most active compounds with NMDAR, mGluR5, and Aβ42. Among the synthesized analogs, 3c, 5b, and 5c emerged as multifunctional compounds that act via multiple anti-AD mechanisms including AChE inhibition, free radical scavenging, NMDA receptor binding, mGluR5 binding, inhibition of Aβ42 fibril formation, and disassembly of preformed Aβ42 fibrils. Interestingly, 5c showed protection against Aβ42-induced toxicity in transgenic C. elegans strain GMC101. Moreover, 5b and 5c displayed high permeability in an MDR1-MDCKII cell-based model of the blood-brain barrier (BBB). Compound 3b emerged with specific activity as a micromolar AChE inhibitor, however it had low permeability in the BBB model. This study highlights the opportunities that exist to develop analogs of endogenous molecules from the kynurenine pathway for therapeutic uses.

Synthesis of bisquinoline-pyrrole oligoamide as G-quadruplex binding ligand

Ong, Chi Wi,Liu, Meng-Chi,Lee, Kun-Da,Chang, Keng Wei,Yang, Ya-Ting,Tung, Hung-Wei,Fox, Keith R.

scheme or table, p. 5453 - 5457 (2012/09/08)

A one-pot procedure using ammonium formate under palladium catalysis for the reductive dechlorination and reduction of nitro group of 4-chloro-8-nitro-quinoline derivatives has be successfully carried out. This has lead to the synthesis of bisquinoline-py

Interplay of interactions governing the dynamic conversions of acyclic and macrocyclic helicates

Campbell, Victoria E.,De Hatten, Xavier,Delsuc, Nicolas,Kauffmann, Brice,Huc, Ivan,Nitschke, Jonathan R.

supporting information; experimental part, p. 6138 - 6142 (2010/03/01)

A rigid, helical macrocycle that contains two copper(I) ions has been synthesized through subcomponent self-assembly. Although it does not obey the "rule of coordinative saturation", this macrocycle could be prepared through subcomponent substitution star

Compositions derived from quinoline and quinoxaline, preparation and use thereof

-

Page/Page column 24, (2008/06/13)

The present invention concerns compounds derived from quinoline and quinoxaline, their preparation and their uses, particularly in the field of therapeutics and vaccines or for developing active compounds. The inventive compounds are of general formula (I

Aromatic δ-peptides: Design, synthesis and structural studies of helical, quinoline-derived oligoamide foldamers

Jiang, Hua,Léger, Jean-Michel,Dolain, Christel,Guionneau, Philippe,Huc, Ivan

, p. 8365 - 8374 (2007/10/03)

Oligoamides of 8-amino-4-isobutoxy-2-quinolinecarboxylic acid were designed and synthesized, and their helical structures were characterized in the solid state by single crystal X-ray diffraction, and in solution by 1H NMR. The monomer methyl 4

Aromatic δ-peptides

Jiang, Hua,Leger, Jean-Michel,Huc, Ivan

, p. 3448 - 3449 (2007/10/03)

Oligoamides of 8-amino-2-carboxy-quinoline adopt a very stable helical conformation characterized in solution by 1H NMR and in the solid state by single-crystal X-ray diffraction. The helix comprises only 2.5 units per turn, which represents th

Synthesis and antiallergic activity of some quinolinones and imidazoquinolinones

Peet,Baugh,Sunder,Lewis

, p. 298 - 302 (2007/10/02)

A group of 1,4-dihydro-4-oxoquinoline-2- and 3-carboxylic acid esters with nitrogen functionality at the 8-position was synthesized, and 6-oxo-6H-imidazo[4,5,1-ij]quinoline-4- and 5-carboxylic acid esters were elaborated from these. Several of the compoun

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 16134-01-3